Hysteroscopy Procedures Market Size, Share & Trends Analysis Report By Procedure (CPT Code 58558, CPT Code 58353), By End-use (Ambulatory Surgical Centers, Hospitals, Clinics), By Region, And Segment Forecasts, 2024 - 2030

Hysteroscopy Procedures Market Size, Share & Trends Analysis Report By Procedure (CPT Code 58558, CPT Code 58353), By End-use (Ambulatory Surgical Centers, Hospitals, Clinics), By Region, And Segment Forecasts, 2024 - 2030


Hysteroscopy Procedures Market Growth & Trends

The global hysteroscopy procedures market size is expected to reach USD 7.4 billion by 2030, expanding at a CAGR of 7.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. Surge in prevalence of gynecological disorders, technological advancements, increasing adoption of minimally invasive surgeries, and favorable reimbursement policies are the key driving factors for the market. In addition, the impact of the COVID-19 pandemic has been significant on the market.

The pandemic has affected companies’ ability to develop and commercialize new & advanced products. Almost all companies are affected by reduced procedure volumes due to the pandemic, as all hospital resources are being diverted to fight the disease. Furthermore, the restrictions and functioning of a limited number of government offices are expected to delay clinical trials of products, which is expected to result in delayed product launches by companies.

The increasing prevalence of uterine fibroids is a key factor driving the market. For instance, as per the research article published in Dove Press Ltd., the prevalence of uterine fibroid disease ranges from 5.4% to 23.6%, depending upon the age group. Moreover, uterine fibroids can cause serious problems in 25% of women. Hysteroscopy is used to diagnose abnormalities, such as excessive bleeding, severe stomach cramps, recurrent miscarriages, or difficulties in conceiving. Thus, the presence of such a large patient pool leads to increased demand for hysteroscopy procedures.

Hysteroscopy Procedures Market Report Highlights
  • The hospitals end-use segment held the largest revenue share of over 52.4% in 2023. The segment growth is credited to the high number of cases of gynecological disorders
  • Asia Pacific is expected to witness the fastest CAGR over the forecast period due to the presence of a large patient pool coupled with the rising aging population in the APAC region
  • Integrating hysteroscopy into office practice will provide a lucrative opportunity for key market players. Several players have launched office hysteroscopy and associated devices
  • For instance, Aveta System (office hysteroscopy), recently launched by Meditrina Inc. in March 2020, is an all-in-one tissue removal solution for intrauterine pathology, which offers wide-angle HD hysteroscopy
  • Furthermore, in-office hysteroscopy is beneficial over traditional hysteroscopy procedures as it is efficient & clinically beneficial and offers a patient-centric approach
  • It is also a simple and quick tool for retrieving intrauterine devices. Thus, physicians will consider investing in equipment and adopting an in-office approach for hysteroscopy
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1. Segment Definitions
1.1.1. CPT Codes
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecasts timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. CPT Codes outlook
2.2.2. End-use outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Hysteroscopy Procedures Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of gynecological disorders
3.2.1.2. Rising adoption of minimally invasive surgical procedures
3.2.1.3. Growing adoption of technologically advanced devices for hysteroscopy procedures
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of hysteroscopy procedures and systems
3.2.2.2. Concerns associated with product approval and commercialization
3.3. Hysteroscopy Procedures Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Hysteroscopy Procedures Market: CPT Codes Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Hysteroscopy Procedures Market: CPT Codes Movement Analysis
4.3. Hysteroscopy Procedures Market by CPT Codes Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. 58555
4.5.1. 58555 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. 58558
4.6.1. 58558 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. 58562
4.7.1. 58562 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. 58340
4.8.1. 58340 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. 58563
4.9.1. 58563 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.10. 58565
4.10.1. 58565 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.11. 58353
4.11.1. 58353 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.12. 58561,74740 and more (Others)
4.12.1. 58561, 74740 and more (Others) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Hysteroscopy Procedures Market: End-use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Hysteroscopy Procedures Market: End-use Movement Analysis
5.3. Hysteroscopy Procedures Market by End-use Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Hospitals
5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Clinics
5.6.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Ambulatory Surgery Centers
5.7.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Hysteroscopy Procedures Market: Regional Estimates & Trend Analysis
6.1. Regional Dashboard
6.2. Regional Hysteroscopy Procedures Market movement analysis
6.3. Hysteroscopy Procedures Market: Regional Estimates & Trend Analysis by CPT Codes & End-use
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. North America
6.5.1. North America Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. U.S.
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement scenario
6.5.2.5. U.S. Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Canada
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement scenario
6.5.3.5. Canada Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. Europe
6.5.5. Europe Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. UK
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Reimbursement scenario
6.5.6.5. UK Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7. Germany
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement scenario
6.5.7.5. Germany Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.8. France
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement scenario
6.5.8.5. France Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.9. Italy
6.5.9.1. Key Country Dynamics
6.5.9.2. Competitive Scenario
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement scenario
6.5.9.5. Italy Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.10. Spain
6.5.10.1. Key Country Dynamics
6.5.10.2. Competitive Scenario
6.5.10.3. Regulatory Framework
6.5.10.4. Reimbursement scenario
6.5.10.5. Spain Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.11. Denmark
6.5.11.1. Key Country Dynamics
6.5.11.2. Competitive Scenario
6.5.11.3. Regulatory Framework
6.5.11.4. Reimbursement scenario
6.5.11.5. Denmark Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.12. Sweden
6.5.12.1. Key Country Dynamics
6.5.12.2. Competitive Scenario
6.5.12.3. Regulatory Framework
6.5.12.4. Reimbursement scenario
6.5.12.5. Sweden Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.13. Norway
6.5.13.1. Key Country Dynamics
6.5.13.2. Competitive Scenario
6.5.13.3. Regulatory Framework
6.5.13.4. Reimbursement scenario
6.5.13.5. Norway Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement scenario
6.6.2.5. Japan Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement scenario
6.6.3.5. China Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement scenario
6.6.4.5. India Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement scenario
6.6.5.5. South Korea Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.6. Australia
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement scenario
6.6.6.5. Australia Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Competitive Scenario
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement scenario
6.6.7.5. Thailand Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Brazil Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. Mexico
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement scenario
6.7.3.5. Mexico Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.4. Argentina
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Reimbursement scenario
6.7.4.5. Argentina Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Middle East & Africa
6.8.1. Middle East & Africa Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement scenario
6.8.2.5. South Africa Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement scenario
6.8.3.5. Saudi Arabia Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement scenario
6.8.4.5. UAE Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement scenario
6.8.5.5. Kuwait Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Key Company Profiles
7.2.1. Medtronic
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Stryker Corporation
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Hologic, Inc.
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. KARL STORZ SE & CO. KG
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Johnson & Johnson (Ethicon, Inc)
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Olympus Corp.
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Delmont Imaging
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. B. Braun Melsungen AG
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Richard Wolf GmbH
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. CooperCompanies
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. Maxer Endoscopy GmbH
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. Boston Scientific Corp.
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
7.2.13. MedGyn Products, Inc.
7.2.13.1. Company overview
7.2.13.2. Financial performance
7.2.13.3. Product benchmarking
7.2.13.4. Strategic initiatives
7.2.14. Lina Medical APS
7.2.14.1. Company overview
7.2.14.2. Financial performance
7.2.14.3. Product benchmarking
7.2.14.4. Strategic initiatives
7.2.15. Luminelle
7.2.15.1. Company overview
7.2.15.2. Financial performance
7.2.15.3. Product benchmarking
7.2.15.4. Strategic initiatives
7.2.16. Meditrina, Inc. (Aveta)
7.2.16.1. Company overview
7.2.16.2. Financial performance
7.2.16.3. Product benchmarking
7.2.16.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings